Please try another search
THC Farmaceuticals, Inc. is engaged in the research and development of cannabis pharmaceutical products. The Company, through its subsidiary, CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The Company is engaged cannabis formulations, edibles, and delivery systems of cannabis. The Company’s facility is located in Southern California. It manufactures and markets cannabis extract products made from cannabis. It provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The Company is focused research on the psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.
Name | Age | Since | Title |
---|---|---|---|
Travis T. Jenson | 48 | 2010 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review